LAPOINTE ANTHONY GREGG received a stock award from RIGEL PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/29/2024ACC: 0000905148-24-001654
Director
Since May 2019
+55K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
55K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25K
Price / share
—
Trade value
—
% of position
33.3%
5/25/2024
75K→100K
Total
Net shares
+25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/25/2024 | A · Award | +25K | — | — | 33.3% | 75K | 100K |
| Total | +25K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
30K shares
Shares
+30K
Strike price
0.9075
Held after
30K
Exercisable
—
5/25/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock30K shares | 5/25/2024 | A · Award | +30K | 0.9075 | — | 30K |